Results 271 to 280 of about 8,855,165 (345)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Information Indicators of Occurrence and Monitoring of Material Structure Degradation in Vibrodiagnostic Systems During Loading. [PDF]

open access: yesMaterials (Basel)
Sharko A   +11 more
europepmc   +1 more source

Towards a minimum reporting standard to promote animal welfare and data quality in biologging research. [PDF]

open access: yesAnim Biotelemetry
Payne AR   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy